logo
add image

Ozempic Kidney Trial Sinks Dialysis Stocks - The Wall Street Journal

Oct. 12, 2023, 7:19 p.m.
Blog single photo

The weight-loss revolution is shaking another industry. Kidney-dialysis stocks sank Wednesday after Novo Nordisk (NVO), (DK: NOVO.B) said a trial showed its blockbuster diabetes drug Ozempic could d… [+251 chars]

Leave Comments

Top